EUVIMEDEUVIMED entdecken
Open Access

Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons

Junming Qian iD, Xiaonan Guan iD, Bing Xie iD, Chuanyun Xu, Jacqueline Niu iD, Xin Tang iD, Charles H Li iD, Henry M Colecraft iD, Rudolf Jaenisch iD, X Shawn Liu iD

Science Translational Medicine · 18.01.2023 · 15 (679)

DOI: 10.1126/scitranslmed.add4666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 18.01.2023. Verfasst von Junming Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cellular Biophysics, Columbia University Medical Center, Columbia University, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Rett Syndrome. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by loss-of-function heterozygous mutations of methyl CpG-binding protein 2 ( MECP2 ) on the X chromosome in young females. Reactivation of the silent wild-type MECP2 allele from the inactive X chromosome (Xi) represents a promising therapeutic opportunity for female patients with RTT. Here, we applied a multiplex epigenome editing approach to reactivate MECP2 from Xi in RTT human embryonic stem cells (hESCs) and derived neurons. Demethylation of the MECP2 promoter by dCas9-Tet1 with target single-guide RNA reactivated MECP2 from Xi in RTT hESCs without detectable off-target effects at the transcriptional level. Neurons derived from methylation-edited RTT hESCs maintained MECP2 reactivation and reversed the smaller soma size and electrophysiological abnormalities, two hallmarks of RTT. In RTT neurons, insulation of the methylation-edited MECP2 locus by dCpf1-CTCF (a catalytically dead Cpf1 fused with CCCTC-binding factor) with target CRISPR RNA enhanced MECP2 reactivation and rescued RTT-related neuronal defects, providing a proof-of-concept study for epigenome editing to treat RTT and potentially other dominant X-linked diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rett SyndromeHumansFemaleEpigenomeMethyl-CpG-Binding Protein 2NeuronsMutationHeterozygoteMixed Function OxygenasesProto-Oncogene Proteins

Substanzen

Methyl-CpG-Binding Protein 2TET1 protein, humanMixed Function OxygenasesProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Physiology and Cellular Biophysics, Columbia University Medical Center, Columbia University, New York, NY 10032, USA.
  • Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
  • Department of Neurosurgery, Boston Children's Hospital, Boston, MA 02465, USA.
  • Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  • Columbia Stem Cell Initiative, Columbia University Medical Center, Columbia University, New York, NY 10032, USA.
  • Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Columbia University, New York, NY 10032, USA.

ORCID-Profile: Junming Qian, Xiaonan Guan, Bing Xie, Jacqueline Niu, Xin Tang, Charles H Li, Henry M Colecraft, Rudolf Jaenisch, X Shawn Liu

Förderung

  • NICHD NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Qian, J., Guan, X., Xie, B., Xu, C., Niu, J., Tang, X., Li, C. H., Colecraft, H. M., Jaenisch, R., & Liu, X. S. (2023). Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons. Science Translational Medicine, 15(679). https://doi.org/10.1126/scitranslmed.add4666

Vancouver

Qian J, Guan X, Xie B, Xu C, Niu J, Tang X, et al. Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons. Science Translational Medicine. 2023;15(679). doi:10.1126/scitranslmed.add4666

BibTeX
@article{Qian2023,
  author = {Qian, Junming and Guan, Xiaonan and Xie, Bing and Xu, Chuanyun and Niu, Jacqueline and Tang, Xin and Li, Charles H and Colecraft, Henry M and Jaenisch, Rudolf and Liu, X Shawn},
  title = {Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons},
  journal = {Science Translational Medicine},
  year = {2023},
  volume = {15},
  number = {679},
  doi = {10.1126/scitranslmed.add4666}
}
Kostenlos starten →